MedPath

Columbia University

Columbia University logo
๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Private
Established
1754-01-01
Employees
20.8K
Market Cap
-
Website
https://www.arch.columbia.edu

Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood

Active, not recruiting
Conditions
Prenatal Diagnosis
Copy Number Abnormality
Genetic Disease
Interventions
Diagnostic Test: Whole Fetal Cell (WFC) Testing
First Posted Date
2020-02-26
Last Posted Date
2024-08-19
Lead Sponsor
Columbia University
Target Recruit Count
33
Registration Number
NCT04285814
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Baylor College of Medicine, Houston, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

Columbia University, New York, New York, United States

Amantadine in Treating Cognitive & Motor Impairments in Adolescents and Adults With Cerebral Palsy

Phase 4
Terminated
Conditions
Cerebral Palsy
Interventions
First Posted Date
2020-02-18
Last Posted Date
2022-05-31
Lead Sponsor
Columbia University
Target Recruit Count
11
Registration Number
NCT04273737
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Columbia University Irving Medical Center, New York, New York, United States

Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)

Not Applicable
Active, not recruiting
Conditions
Eye Diseases
Diabetic Retinopathy
Glaucoma
Cataract
Vision Impairment and Blindness
Interventions
Other: Usual Care
Behavioral: Enhanced Intervention Using Patient Navigators
First Posted Date
2020-02-17
Last Posted Date
2024-11-01
Lead Sponsor
Columbia University
Target Recruit Count
749
Registration Number
NCT04271709
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Columbia University, New York, New York, United States

Family-Based Intervention Study of the Effects of Environmental Exposures on Breast Tissue Composition

Not Applicable
Conditions
Breast Cancer Risk
Interventions
Behavioral: Breast Cancer Risk Reduction Household Intervention
First Posted Date
2020-02-11
Last Posted Date
2020-02-11
Lead Sponsor
Columbia University
Target Recruit Count
90
Registration Number
NCT04265547
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Columbia University Mailman School of Public Health, New York, New York, United States

Mechanistic Clinical Trial of Individualized tDCS for Hallucinations in Schizophrenia

Not Applicable
Withdrawn
Conditions
Schizophrenia and Related Disorders
Interventions
Device: neuroConn DC-Stimulator MR
Device: Soterix MxN HD-tES
First Posted Date
2020-01-30
Last Posted Date
2022-04-05
Lead Sponsor
Columbia University
Registration Number
NCT04248010

Doppler Ultrasound Compared With Stethoscope to Assess Heart Rate (HR)

Not Applicable
Completed
Conditions
Neonatal Resuscitation
Interventions
Procedure: Handheld fetal doppler ultrasound
First Posted Date
2020-01-27
Last Posted Date
2022-01-10
Lead Sponsor
Columbia University
Target Recruit Count
32
Registration Number
NCT04242654
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Columbia University Irving Medical Center, New York, New York, United States

Procalcitonin Guided Antibiotic Therapy

Not Applicable
Withdrawn
Conditions
Intra-Abdominal Infections
Interventions
Other: Procalcitonin-guided antibiotic treatment
Other: Standard of Care Antibiotic Treatment
First Posted Date
2020-01-27
Last Posted Date
2021-10-21
Lead Sponsor
Columbia University
Registration Number
NCT04240288

Autoimmune Features of Neurodegenerative Disorders

Recruiting
Conditions
Alzheimer Disease
Parkinson Disease
Mild Cognitive Impairment
First Posted Date
2020-01-23
Last Posted Date
2024-08-01
Lead Sponsor
Columbia University
Target Recruit Count
120
Registration Number
NCT04239079
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Columbia University Medical Center, New York, New York, United States

BabyQ's: Randomized Controlled Trial of Health Messaging in Pregnancy and Infancy

Not Applicable
Completed
Conditions
Infant Development
Pregnancy Related
Interventions
Behavioral: Mobile messaging
First Posted Date
2020-01-23
Last Posted Date
2021-11-16
Lead Sponsor
Columbia University
Target Recruit Count
291
Registration Number
NCT04238585
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Columbia University, New York, New York, United States

Copanlisib in Combination With Romidepsin in Patients With Relapsed or Refractory Mature T-cell Lymphoma

Phase 1
Withdrawn
Conditions
Lymphoma, T-Cell
Interventions
First Posted Date
2020-01-18
Last Posted Date
2020-08-13
Lead Sponsor
Columbia University
Registration Number
NCT04233697
ยฉ Copyright 2025. All Rights Reserved by MedPath